Module

The Epidemic of Hepatocellular Carcinoma: Diagnosis and Therapy

Source: Hepatitis Annual Update 2007

The Epidemic of Hepatocellular Carcinoma: Diagnosis and Therapy

Faculty:

Gary L. Davis, MD

CREDIT INFORMATION

Release Date: July 16, 2007

Expiration Date: July 15, 2008

Physicians: maximum of 1.25 AMA PRA Category 1 Credits™

Registered Nurses: 1.3 Nursing contact hours

Pharmacists: 1.3 contact hours (0.13 CEUs)

Status: The activity is not currently available for credit.

Learning Objectives

Upon completion of this activity, participants should be able to:

Describe the changing demographics and epidemiology of hepatocellular carcinoma
Assess strategies of surveillance for and diagnosis of hepatocellular cancer
Summarize the various options for management of hepatocellular carcinoma

Topics covered include:

Introduction
Epidemiology
Risk Factors
- Chronic Viral Hepatitis
- Alcohol
- Other
Pathogenesis
Diagnosis
- Serologic Methods
- Imaging and Biopsy
Surveillance Strategies
Treatment Options
- Locoregional Ablation
- Surgical
- Other
Conclusion
Summary: Implications for Clinical Practice

Disclaimer: The materials published on the Clinical Care Options Sites reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.